Three years experience with drotrecogin alfa (activated) protein C in severe sepsis and septic shock at Salmaniya Medical Complex, Bahrain

Podobne zapisy

• Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock
  od: Spapen, Herbert, i wsp.
  Wydane: (2010)
• An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock
  od: Lai, Peggy S., i wsp.
  Wydane: (2012)
• Severe sepsis and drotrecogin alfa (activated) use: results from the PROGRESS registry
  od: Beale, R, i wsp.
  Wydane: (2007)
• Introduction: severe sepsis and drotrecogin alfa (activated)
  od: Artigas, Antonio, i wsp.
  Wydane: (2007)
• Severe sepsis and septic shock in Croatian ICUs
  od: Gornik, I, i wsp.
  Wydane: (2006)